The Omnibus Satiety Metric: Predicting Satiety in Humans Through Brain, Blood, and Subjective Data
OmniSaM
The Omnibus Satiety Metric (OmniSaM)
1 other identifier
interventional
24
1 country
1
Brief Summary
Designing food and drink that maximizes satiety has long been an ambition of industry and public health. For obvious reasons, foods that fill faster and for longer are desirable to consumers for controlling their weight, and to public health programs that are designed to prevent obesity. Current methods for measuring satiety have weak predictive value, commonly fail to replicate, and are yet to be validated with respect to energy consumption in everyday life. The investigators propose to overcome this deficiency by developing the Omnibus Satiety Metric (OmniSaM). OmniSaM is proposed as a multi-modal metric that targets the full spectrum of processes underlying the satiety cascade, composing brain, blood, mind and behavior of consumers. As a proof-of-concept, subjects (normal BMI) will undergo a preload ad libitum paradigm, with a 2-parameter factorial design comparing milk based products differing in levels of caloric load and protein-to-carbohydrate ratio. The investigators will acquire 1. high-resolution neuroimaging data, whilst 2. simultaneously recording appetitive hormones, 3. blood metabolite composition, 4. subjective sensory indices of appetite and 4. behavioral metrics of consumption.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 18, 2017
CompletedFirst Submitted
Initial submission to the registry
March 25, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2019
CompletedFirst Posted
Study publicly available on registry
April 2, 2019
CompletedSeptember 25, 2019
September 1, 2019
1.5 years
March 25, 2019
September 24, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ad libitum energy consumption
The energy content in calories of the spaghetti consumed under ad libitum conditions
3 hours after the preload
Study Arms (1)
Full group
EXPERIMENTALThere is only one arm in this study. The group of 25 subjects all undergo a repeated measures 2 x 2 factorial design, fully crossed such that all subjects are tested under all four combinations of factors. The intervention "Preload" amounts to two factors, caloric load and protein to carbohydrate ratio of the preload, both of which can take on two levels high or low.
Interventions
In the 2 x 2 factorial design we vary two factors: 1. caloric load of the preload such that it is either high calorie or low. 2. protein to carbohydrate ratio of the preload such that it is either high or low
Eligibility Criteria
You may qualify if:
- Healthy male
- Aged 20-40 years old
- Normal hematology, kidney and liver function
- Normal weight (BMI 18.5-24.9)
- Weight stable defined as +/- 5 kg within 3 months prior to test start
- Liking milk
- Liking spaghetti bolognaise
You may not qualify if:
- Suffer or have suffered from any metabolic disorders
- Suffer or have suffered from any psychiatric disorders
- Suffer or have suffered from any neurological disorders
- Restrained eating behavior or caloric restriction
- Claustrophobia
- Implanted with pacemakers or other implanted electronic devices
- Concentration of hemoglobin \<8mMol/L,
- Alanintransaminase \>70 U/L
- Alkaline phosphatase \>105 U/L
- Bilirubin \>25 micromol/L
- Coagulationfactors (INR) \>1.2
- eGFR \<60 ml/min
- hba1c \>48 mmol/mol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Derek Victor Byrnelead
- University of Copenhagencollaborator
- Danish Research Centre for Magnetic Resonancecollaborator
Study Sites (1)
Oliver Hulme
København S, Region Sjælland, 2300, Denmark
MeSH Terms
Conditions
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- The study is a repeated measures design. It is double blinded in the sense that the participant, brain imager and endocrinologist are masked from the preload condition. One technician is unblinded as to the preload type. The participant is not aware of the possible ways in which the preload can vary, or even that it could vary over testdays.
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 25, 2019
First Posted
April 2, 2019
Study Start
October 18, 2017
Primary Completion
April 1, 2019
Study Completion
April 1, 2019
Last Updated
September 25, 2019
Record last verified: 2019-09